Pharmacodynamics New
Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of
drugs (especially pharmaceutical drugs). The effects can include those manifested within animals (including humans), microorganisms, or combinations of organisms (for example, infection)
Pharmacokinetics (PK) refers to the movement of
drugs through the body, whereas pharmacodynamics (PD) refers to the body's biological response to drugs. PK describes a drug's exposure by characterizing absorption, distribution, bioavailability, metabolism, and excretion as a function of time. Pharmacodynamics is defined as the response of the body to the drug. It refers to the relationship between drug concentration at the site of action and any resulting effects namely, the intensity and time course of the effect and adverse effects. Pharmacodynamics (sometimes described as what a drug does to the body) is the study of the biochemical, physiologic, and molecular effects of
drugs on the body and involves receptor binding (including receptor sensitivity), postreceptor effects, and chemical interactions. Pharmacodynamics, with
pharmacokinetics (what the body does to a drug, or the fate of a drug within the body), helps explain the relationship between the dose and response, ie, the drug's effects. The pharmacologic response depends on the drug binding to its target
High Impact List of Articles
-
Short-term efficacy of incretin-related drugs among Asian patients monitored by glucose area under the curve calculated without blood sampling
Keisuke Kosugi*, Kenya Sakamoto, Kazutomi Yoshiuchi, Toshiyuki Sato, Seiki Okada, Yasuhito Ohnishi, Hiroyuki Koga, Kazutoshi Tokunaga, Chihiro Suminaka & Hiromu Nakajima
Research Article: Diabetes Management
-
Short-term efficacy of incretin-related drugs among Asian patients monitored by glucose area under the curve calculated without blood sampling
Keisuke Kosugi*, Kenya Sakamoto, Kazutomi Yoshiuchi, Toshiyuki Sato, Seiki Okada, Yasuhito Ohnishi, Hiroyuki Koga, Kazutoshi Tokunaga, Chihiro Suminaka & Hiromu Nakajima
Research Article: Diabetes Management
-
Targeting abdominal obesity in diabetes
Thinzar Min & Jeffrey Wayne Stephens
Review Article: Diabetes Management
-
Targeting abdominal obesity in diabetes
Thinzar Min & Jeffrey Wayne Stephens
Review Article: Diabetes Management
-
Canagliflozin for Type 2 diabetes: an up-to-date evidence summary
Aris Liakos, Thomas Karagiannis, Eleni Bekiari & Apostolos Tsapas
Review Article: Diabetes Management
-
Canagliflozin for Type 2 diabetes: an up-to-date evidence summary
Aris Liakos, Thomas Karagiannis, Eleni Bekiari & Apostolos Tsapas
Review Article: Diabetes Management
-
Cognitive impairment and dementia in Type 2 diabetes
David G Bruce
Editorial: Diabetes Management
-
Cognitive impairment and dementia in Type 2 diabetes
David G Bruce
Editorial: Diabetes Management
-
Role of ghrelin in glucose homeostasis and diabetes
Katherine A Banks & Kevin G Murphy
Review Article: Diabetes Management
-
Role of ghrelin in glucose homeostasis and diabetes
Katherine A Banks & Kevin G Murphy
Review Article: Diabetes Management
-
Biomarkers for evaluating renal function decline in diabetes: where are we now?
Janet K Snell-Bergeon
Review Article: Diabetes Management
-
Biomarkers for evaluating renal function decline in diabetes: where are we now?
Janet K Snell-Bergeon
Review Article: Diabetes Management
-
The dead in bed syndrome revisited:a review of the evidence
Philip J Weston
Review Article: Diabetes Management
-
The dead in bed syndrome revisited:a review of the evidence
Philip J Weston
Review Article: Diabetes Management
-
Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents
Linda Gonder-Frederick, Maren Nyer, Jaclyn A Shepard, Karen Vajda & William Clarke
Review Article: Diabetes Management
-
Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents
Linda Gonder-Frederick, Maren Nyer, Jaclyn A Shepard, Karen Vajda & William Clarke
Review Article: Diabetes Management
Relevant Topics in Clinical